← Open Payments lookup

CHANTAL TCHOUMBA: Open Payments

NPI 1962917864 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$597 in 26 payments from 5 companies in 2025. Trend: 2023 $146 · 2024 $446 · 2025 $597

Food & beverage: $597
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.15$350
ABBVIE INC.7$179
Lundbeck LLC2$30
Otsuka America Pharmaceutical, Inc.1$21
E.R. Squibb & Sons, L.L.C.1$18

Products named: INGREZZA, VRAYLAR, ABILIFY ASIMTUFII, REXULTI, COBENFY.

Industry payments across MD — which companies pay providers there.